Position in VTRS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,459,782
+$358,929 QoQ
Shares Held
108,052
+22.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$23,961
PutShares
2,401
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
419,904 | $49,636,851 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
224,067 | $6,748,898 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,894 | $2,902,044 | |
| 4 | HLN |
Haleon plc
|
192,177 | $1,923,691 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
103,082 | $1,909,078 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 7 | VTRS |
Viatris Inc
This page
|
108,052 | $1,459,782 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
93,386 | $1,160,787 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,459,782 | 108,052 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,100,853 | 88,422 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $923,392 | 93,272 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $848,341 | 94,999 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,981,098 | 227,451 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,894,151 | 232,462 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,029,273 | 347,052 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,818,059 | 171,031 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,208,470 | 184,964 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,314,425 | 213,705 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,387,490 | 242,139 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,477,305 | 248,227 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $23,961 | 2,401 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $1,887,444 | 196,200 | Call | Sole | 2023-05-12 | |
| 2023-03-31 | $2,340,315 | 243,276 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,197,860 | 287,319 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,682,249 | 314,818 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,557,245 | 339,756 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,229,795 | 388,768 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,594,476 | 339,577 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,311,955 | 465,827 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,975,077 | 488,109 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,122,981 | 438,295 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||